Skin photodamage/photoaging
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients clinically diagnosed with skin photoinjury; 2) Age 18 to 60 years old; 3) The patient voluntarily participated in this clinical study and signed a written informed consent form.
Exclusion criteria
Exclusion criteria: 1) Exposure to other skin diseases such as melasma, freckles, and seborrheic dermatitis at the exposed site may affect the judgment of the test results; 2) Individuals with allergies to experimental drugs or high sensitivity constitution; 3) Pregnant, quasi pregnant, or lactating patients; 4) The laboratory examination results of liver function and kidney function were judged by the doctor as clinically significant abnormalities; 5) Patients who took oral antioxidant drugs or topical hormone drugs within 4 weeks before the trial; Patients who have undergone physical therapy for skin photodamage; 6) Patients with a history of facial injection or surgery 2 months prior to the trial; 7) Patients with immunodeficiency diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate;safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin loss reduction rate;Skin lesion score;VISIA score improvement rate;Skin detector checks skin barrier function; | — |
Countries
China
Contacts
Department of Dermatology, West China Hospital, Sichuan University.